Article citationsMore>>

Spitler, L.E., Weber, R.W., Allen, R.E., Meyer, J., Cruickshank, S., Garbe, E., Lin, H.Y. and Soong, S.J. (2009) Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF, Ssargramostim) Administered for 3 Years as Adjuvant Therapy of Stages II(T4), III, and IV Melanoma. Journal of Immunotherapy, 32, 632-637.
https://doi.org/10.1097/CJI.0b013e3181a7d60d

has been cited by the following article:

• TITLE: Supportive and Palliative Care in Cancer Therapies—Path from Tumor-Driven Therapies to Patient-Driven Ones

  AUTHORS: Carrie Anne Minnaar, Andras Szasz, Sun Young Lee, Gyula Peter Szigeti, Attila Marcell Szasz, Domokos Mathe

  KEYWORDS: Cancer, Vitamins, Minerals, Fungi, Immune, Phytomedicine, Complexity, Electric-Stimuli, Hyperthermia, mEHT

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.13 No.7, July 29, 2022

  ABSTRACT: Cancer patients frequently report a set of symptoms including fatigue, pain, and physiological and social distress. Families and other personal lay relations give proposals to take supportive drugs and supplemental nutrients, without professional knowledge about their actions. Internet search engines and social networks serve up most of the treatment proposals, opening wide possibilities for quackeries and predatory money-making practices. Medical professionals have a responsibility to clear this field and concentrate on patients’ well-being and personal needs. According to our approach, the integration of supportive and palliative care with conventional therapies needs a change of paradigm from tumour-driven to patient-driven treatment actions. Supportive/palliative care includes a broad spectrum of applied methods, including medications, nourishments, electrical effects, and psycho and social supports. Our goal is to discuss the possibilities for combining conventional oncotherapies with additional supportive/palliative care and to give suggestions on a professional basis.